M-175
MDPBP-D8 hydrochloride solution
100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
InChI key
ATCKCJHEOJFKJW-SOLWPGNYSA-N
SMILES string
CCC(N1C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H])C(C2=CC(OCO3)=C3C=C2)=O.[H]Cl
InChI
1S/C15H19NO3.ClH/c1-2-12(16-7-3-4-8-16)15(17)11-5-6-13-14(9-11)19-10-18-13;/h5-6,9,12H,2-4,7-8,10H2,1H3;1H/i3D2,4D2,7D2,8D2;
grade
certified reference material
form
liquid
feature
(Snap-N-Spike®)
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
drug control
Narcotic Licence Schedule E (Switzerland)
concentration
100 μg/mL in methanol (as free base)
technique(s)
gas chromatography (GC): suitable, liquid chromatography (LC): suitable
application(s)
pharmaceutical (small molecule)
format
single component solution
storage temp.
−20°C
General description
A novel designer drug first developed in the 1960′s as a research chemical, MDPBP emerged as a legal high in Europe in 2009. This synthetic cathinone and bath salt is often sold in the US and other countries under the name "NRG-1" as a mixture with other substituted cathinone derivatives such as flephedrone, pentylone, and MDPV. This Certified Spiking Solution® is suitable as an internal standar for MDPBPP testing methods by GC/MS or LC/MS in forensic analysis, clinical toxicology, or urine drug testing applications.
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
target_organs
Eyes
存储类别
3 - Flammable liquids
wgk
WGK 1
flash_point_f
49.5 °F - closed cup
flash_point_c
9.7 °C - closed cup
法规信息
监管及禁止进口产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持